Marshall Wace Portfolio holdings
AUM
$84.1B
1-Year Return
27.54%
This Quarter Return
+16.58%
1 Year Return
+27.54%
3 Year Return
+105.03%
5 Year Return
+179.94%
10 Year Return
+445.45%
AUM
$84.1B
AUM Growth
+$9.18B
(+12%)
Cap. Flow
-$227M
Cap. Flow
% of AUM
-0.27%
Top 10 Holdings %
Top 10 Hldgs %
33.22%
Holding
3,151
New
699
Increased
893
Reduced
848
Closed
646
Top Buys
| 1 |
CRCL
Circle Internet Group, Inc.
CRCL
|
+$1.55B |
| 2 |
NVIDIA
NVDA
|
+$1.14B |
| 3 |
Amazon
AMZN
|
+$488M |
| 4 |
T-Mobile US
TMUS
|
+$421M |
| 5 |
Eli Lilly
LLY
|
+$399M |
Top Sells
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$1.41B |
| 2 |
Tesla
TSLA
|
+$928M |
| 3 |
Danaher
DHR
|
+$545M |
| 4 |
Intuit
INTU
|
+$543M |
| 5 |
Meta Platforms (Facebook)
META
|
+$464M |
Sector Composition
| 1 | Technology | 21.23% |
| 2 | Consumer Discretionary | 14.33% |
| 3 | Healthcare | 10.99% |
| 4 | Financials | 9.07% |
| 5 | Communication Services | 7.65% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
AKYA
2376
DELISTED
Akoya BioSciences
AKYA
| $96K | ﹤0.01% |
+73,881
| New | +$96K |
|
2377
Telomir Pharmaceuticals
TELO
$46M
| $94.7K | ﹤0.01% |
+75,770
| New | +$94.7K |
|
2378
Diana Shipping
DSX
$228M
| $94.3K | ﹤0.01% |
64,566
-12,044
| -16% | -$17.6K |
|
2379
Lyell Immunopharma
LYEL
$253M
| $93.5K | ﹤0.01% |
+10,580
| New | +$93.5K |
|
2380
Relmada Therapeutics
RLMD
$51.8M
| $92.7K | ﹤0.01% |
+154,568
| New | +$92.7K |
|
2381
Genelux
GNLX
$139M
| $92.5K | ﹤0.01% |
+32,221
| New | +$92.5K |
|
2382
PDS Biotechnology
PDSB
$55.5M
| $91K | ﹤0.01% |
+68,454
| New | +$91K |
|
2383
Tenaya Therapeutics
TNYA
$212M
| $90.3K | ﹤0.01% |
+148,089
| New | +$90.3K |
|
2384
Renovaro
RENB
$51.3M
| $89.7K | ﹤0.01% |
+309,350
| New | +$89.7K |
|
2385
Atea Pharmaceuticals
AVIR
$251M
| $89.5K | ﹤0.01% |
+24,867
| New | +$89.5K |
|
|
MVO
2386
MV Oil Trust
MVO
$68.4M
| $88K | ﹤0.01% |
+15,270
| New | +$88K |
|
2387
FerroAtlántica
GSM
$782M
| $87.7K | ﹤0.01% |
23,900
-791,613
| -97% | -$2.91M |
|
2388
Amicus Therapeutics
FOLD
$2.43B
| $86.3K | ﹤0.01% |
15,062
-181,051
| -92% | -$1.04M |
|
2389
UNIFI
UFI
$81.5M
| $86.1K | ﹤0.01% |
16,492
-86,745
| -84% | -$453K |
|
2390
Altimmune
ALT
$334M
| $85.5K | ﹤0.01% |
22,100
-1,146,238
| -98% | -$4.44M |
|
2391
LanzaTech
LNZA
$45.4M
| $82.2K | ﹤0.01% |
+3,045
| New | +$82.2K |
|
|
HURA
2392
TuHURA Biosciences, Inc. Common Stock
HURA
$118M
| $79.3K | ﹤0.01% |
+35,571
| New | +$79.3K |
|
|
ARTV
2393
Artiva Biotherapeutics, Inc. Common Stock
ARTV
$67.9M
| $78.8K | ﹤0.01% |
+52,213
| New | +$78.8K |
|
2394
Century Therapeutics
IPSC
$43.4M
| $78.2K | ﹤0.01% |
+139,707
| New | +$78.2K |
|
2395
TScan Therapeutics
TCRX
$104M
| $77.8K | ﹤0.01% |
+53,678
| New | +$77.8K |
|
2396
Green Plains
GPRE
$657M
| $77K | ﹤0.01% |
12,771
-386,724
| -97% | -$2.33M |
|
2397
CervoMed
CRVO
$87M
| $75.6K | ﹤0.01% |
+12,017
| New | +$75.6K |
|
2398
Annexon
ANNX
$233M
| $72K | ﹤0.01% |
+29,989
| New | +$72K |
|
2399
Smart Sand
SND
$75.5M
| $71.9K | ﹤0.01% |
35,749
-31,953
| -47% | -$64.2K |
|
|
AUNA
2400
Auna
AUNA
$471M
| $70.9K | ﹤0.01% |
11,428
-10,553
| -48% | -$65.4K |
|